Page last updated: 2024-10-28

halothane and Alcoholic Liver Diseases

halothane has been researched along with Alcoholic Liver Diseases in 3 studies

Research Excerpts

ExcerptRelevanceReference
" Fourteen modified, apparently correctly folded CYP2E1 variants were produced in Escherichia coli and evaluated in immunoprecipitation experiments using sera with anti-CYP2E1 autoreactivity from 10 patients with halothane hepatitis and 12 patients with alcoholic liver disease."3.72Use of molecular simulation for mapping conformational CYP2E1 epitopes. ( Albano, E; Eliasson, E; Hidestrand, M; Ingelman-Sundberg, M; Mottaran, E; Occhino, G; Reale, E; Rolla, R; Vidali, M, 2004)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laverty, HG1
Antoine, DJ1
Benson, C1
Chaponda, M1
Williams, D1
Kevin Park, B1
Vidali, M1
Hidestrand, M1
Eliasson, E1
Mottaran, E1
Reale, E1
Rolla, R1
Occhino, G1
Albano, E1
Ingelman-Sundberg, M1
Neuberger, J1
Williams, R1

Reviews

2 reviews available for halothane and Alcoholic Liver Diseases

ArticleYear
The potential of cytokines as safety biomarkers for drug-induced liver injury.
    European journal of clinical pharmacology, 2010, Volume: 66, Issue:10

    Topics: Acetaminophen; Anesthetics, Inhalation; Animals; Biomarkers; Chemical and Drug Induced Liver Injury;

2010
Immunology of drug and alcohol-induced liver disease.
    Bailliere's clinical gastroenterology, 1987, Volume: 1, Issue:3

    Topics: Acute Disease; Animals; Antibody Formation; Chemical and Drug Induced Liver Injury; Chronic Disease;

1987

Other Studies

1 other study available for halothane and Alcoholic Liver Diseases

ArticleYear
Use of molecular simulation for mapping conformational CYP2E1 epitopes.
    The Journal of biological chemistry, 2004, Dec-03, Volume: 279, Issue:49

    Topics: Anesthetics, Inhalation; Computer Simulation; Crystallography, X-Ray; Cytochrome P-450 CYP2E1; Cytoc

2004